Hemoglobin Southampton complicated by cerebral ischemia, moyamoya, and hydroxyurea-induced methemoglobinemia

Am J Hematol. 2019 Aug;94(8):949-954. doi: 10.1002/ajh.25509. Epub 2019 Jun 7.

Authors

Alexander A Boucher^{1

2}, Arun Gurunathan^{1

2}, John M Taylor^{2

3}, Kiersten W Ricci^{1

2}, Sudhakar Vadivelu^{2

4}, Charles T Quinn^{1

2}

Affiliations

¹ Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
² University of Cincinnati College of Medicine, Cincinnati, Ohio.
³ Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
⁴ Neurosurgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

PMID: 31095774
DOI: 10.1002/ajh.25509

No abstract available

Publication types

Case Reports

MeSH terms

Aspirin / administration & dosage
Aspirin / therapeutic use
Brain Ischemia / blood
Brain Ischemia / complications*
Brain Ischemia / genetics
Brain Ischemia / therapy
Child
Female
Hemoglobinopathies / blood
Hemoglobinopathies / complications*
Hemoglobinopathies / genetics
Hemoglobinopathies / therapy
Hemoglobins, Abnormal / genetics*
Humans
Hydroxyurea / adverse effects*
Hydroxyurea / therapeutic use
Methemoglobinemia / blood
Methemoglobinemia / chemically induced*
Moyamoya Disease / blood
Moyamoya Disease / complications*
Moyamoya Disease / genetics
Moyamoya Disease / therapy
Treatment Outcome

Substances

Hemoglobins, Abnormal
Aspirin
Hydroxyurea